Literature DB >> 11307054

Ocular manifestations of central nervous system lymphoma.

R R Buggage1, C C Chan, R B Nussenblatt.   

Abstract

Primary intraocular lymphoma (PIOL) is a variant of primary central nervous system lymphoma in which lymphoma cells are initially present only in the eyes without evidence of disease in the brain or cerebrospinal fluid. Patients with PIOL are typically older adults who present with blurred vision and floaters. The ophthalmic examination characteristically shows a cellular infiltrate in the vitreous with or without the presence of subretinal infiltrates. Diagnostic evaluation for PIOL includes neuroimaging, cytologic examination of the cerebrospinal fluid, and a diagnostic vitrectomy with special handling of the vitreous specimen, if the former is nondiagnostic. Molecular and cytokine analyses are useful adjuncts to cytology for the diagnosis of PIOL. Recent molecular studies demonstrating viral DNA in the ocular lymphoma cells suggest a role for infectious agents in the pathogenesis of PIOL. To date, the best mode for treatment of PIOL or recurrent primary central nervous system lymphoma involving only the eyes remains undefined.

Entities:  

Mesh:

Year:  2001        PMID: 11307054     DOI: 10.1097/00001622-200105000-00001

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  26 in total

Review 1.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 2.  Management of primary intraocular lymphoma.

Authors:  Stella K Kim; Chi-Chao Chan; Dana J Wallace
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

3.  Radiotherapy of indolent orbital lymphomas : Two radiation concepts.

Authors:  Laila König; Robert Stade; Juliane Rieber; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2016-05-09       Impact factor: 3.621

Review 4.  International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.

Authors:  Robert B Nussenblatt; Chi-Chao Chan; Wyndham H Wilson; Jacob Hochman; Michael Gottesman
Journal:  Ocul Immunol Inflamm       Date:  2006-06       Impact factor: 3.070

Review 5.  Intraocular lymphoma.

Authors:  Li-Juan Tang; Chang-Lin Gu; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.

Authors:  Zhuqing Li; Sankaranarayana P Mahesh; De Fen Shen; Baoying Liu; Willie O Siu; Frank S Hwang; Qing-Chen Wang; Chi-Chao Chan; Ira Pastan; Robert B Nussenblatt
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

8.  Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.

Authors:  Noriyasu Hashida; Kei Nakai; Norimitsu Saitoh; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-19       Impact factor: 3.117

9.  Ifosfamide or trofosfamide in patients with intraocular lymphoma.

Authors:  Kristoph Jahnke; Eckhard Thiel; Nikolaos E Bechrakis; Gregor Willerding; Dale F Kraemer; Lars Fischer; Agnieszka Korfel
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

10.  Differentiation of malignant B-lymphoma cells from normal and activated T-cell populations by their intrinsic autofluorescence.

Authors:  Seth M Pantanelli; Zhuqing Li; Robert Fariss; Sankaranarayana P Mahesh; Baoying Liu; Robert B Nussenblatt
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.